Related Articles
Validity of an NGS‑based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital
The evolution in melanoma treatment as a reflection of precision-oriented medicine (Review)
Importance of driver gene mutation assessment and targeted therapy for patients with early‑stage non‑small cell lung cancer and non‑R0 resection
Somatic alterations in brain tumors
How specific molecular‑targeted agents can make obsolete a ‘one size fits all’ approach in <em>EGFR</em>‑mutated NSCLC treatment (Review)